← Leaderboards
Yi Huang
University Of Pittsburgh At Pittsburgh
$1,791,828
Attributed
$1,791,828
Total exposure
1
Grants
1
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $372.9K · FY2021–25$500K$375K$250K$125K$0
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$1,791,828 · 1
By mechanism
R01$1,791,828 · 1
Top collaborators
No co-investigators on record.
Most similar at University Of Pittsburgh At Pittsburgh
Same institution · by research overlap
- Kathryn S. Torok$2,024,095
- Joel S Greenberger$22,565,586
- Heidi T Jacobe$1,705,648
- Solomon Fiifi Ofori-Acquah$18,588,176
- Delphine Gomez$3,973,818
Others in their field
Other Emerging Leaders on “Mediating”
- Bambra Strokes · Ppd Development Lp$526,656,217
- Yunda Huang · Fred Hutchinson Cancer Center$73,602,469
- James Dale Berry · Brigham And Women'S Hospital$25,538,716
- Ionut Bebu · George Washington University$18,816,779
- Barbara Halina Braffett · George Washington University$18,816,779
- Gary Fanger · Rise Therapeutics, Llc$17,847,765
Research focus
MediatingPre-ClinicalEpigenetic SilencingMalignant Breast NeoplasmMouse ModelOverexpressionChemotherapyEpigenetic ProcessImmunogenicKdm1a GeneMolecularBreast Cancer CellNeoplasm MetastasisBreast Cancer ProgressionAblationChemokineClinically RelevantEffector T CellGenetically Engineered MouseHistonesInsightIn VivoCd8-Positive T-LymphocytesPrognosis
Grant awards (6)
Role of LSD1 in Triple Negative Breast Cancer Development and Therapeutic Response$345,700
R01 · FY2025 · CA · contact PI
Role of LSD1 in Triple Negative Breast Cancer Development and Therapeutic Response$332,124
R01 · FY2024 · CA · contact PI
Role of LSD1 in Triple Negative Breast Cancer Development and Therapeutic Response$40,735
R01 · FY2024 · CA · contact PI
Role of LSD1 in Triple Negative Breast Cancer Development and Therapeutic Response$348,592
R01 · FY2023 · CA · contact PI
Role of LSD1 in Triple Negative Breast Cancer Development and Therapeutic Response$366,683
R01 · FY2022 · CA · contact PI
Role of LSD1 in Triple Negative Breast Cancer Development and Therapeutic Response$357,994
R01 · FY2021 · CA · contact PI